<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font26 { font-size : 26; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">HEV </span>
   <span class="font26">(.–.) </span>
   <span class="font20">anti-HEV </span>
   <span class="font19">hepatitis </span>
   <span class="font17">IgM </span>
   <span class="font16">acute </span>
   <span class="font15">IgG </span>
   <span class="font15">assays </span>
   <span class="font15">virus </span>
   <span class="font15">CI) </span>
   <span class="font15">RNA </span>
   <span class="font15">serological </span>
   <span class="font15">{border-style </span>
   <span class="font14">infection </span>
   <span class="font14">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">Wantai </span>
   <span class="font14">kits </span>
   <span class="font13">(–) </span>
   <span class="font13">ELISA </span>
   <span class="font13">Genelabs </span>
   <span class="font13">diagnosis </span>
   <span class="font13">results </span>
   <span class="font13">Lizhu </span>
   <span class="font13">Kehua </span>
   <span class="font13">detection </span>
   <span class="font13">different </span>
   <span class="font12">assays. </span>
   <span class="font12">patients </span>
   <span class="font12">positive </span>
   <span class="font12">(.–) </span>
   <span class="font12">Kappa </span>
   <span class="font12">antibodies </span>
   <span class="font12">tests </span>
   <span class="font12">using </span>
   <span class="font12">(–.–.) </span>
   <span class="font12">assay </span>
   <span class="font12">genotype </span>
   <span class="font12">&amp;lt; </span>
   <span class="font12">However, </span>
   <span class="font12">Specificity </span>
   <span class="font12">Table </span>
   <span class="font12">diagnostic </span>
   <span class="font12">infections </span>
   <span class="font12">px; </span>
   <span class="font12">specific </span>
   <span class="font12">specificity </span>
   <span class="font12">{font-family </span>
   <span class="font11">(.) </span>
   <span class="font11">Clin </span>
   <span class="font11">Concordance </span>
   <span class="font11">Tianjin </span>
   <span class="font11">clinical </span>
   <span class="font11">font-size </span>
   <span class="font11">infection. </span>
   <span class="font11">performance </span>
   <span class="font11">sensitivity </span>
   <span class="font11">used </span>
   <span class="font11">(%) </span>
   <span class="font11">(Table </span>
   <span class="font11">Clinical </span>
   <span class="font11">Med </span>
   <span class="font11">cases </span>
   <span class="font11">commercial </span>
   <span class="font11">double; </span>
   <span class="font11">genotypes </span>
   <span class="font11">kit </span>
   <span class="font11">population </span>
   <span class="font11">significant </span>
   <span class="font11">viral </span>
   <span class="font11">(.–.%) </span>
   <span class="font11">;():–. </span>
   <span class="font11">Central </span>
   <span class="font11">Commercial </span>
   <span class="font11">Infect </span>
   <span class="font11">agreement </span>
   <span class="font11">antigen </span>
   <span class="font11">available </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">including </span>
   <span class="font11">non-HEV </span>
   <span class="font11">present </span>
   <span class="font11">serum </span>
   <span class="font11">showed </span>
   <span class="font11">solid; </span>
   <span class="font11">study, </span>
   <span class="font11">total </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(HEV) </span>
   <span class="font11">CMV </span>
   <span class="font11">CMV/EBV </span>
   <span class="font11">Department </span>
   <span class="font11">PCR </span>
   <span class="font11">blood </span>
   <span class="font11">bold </span>
   <span class="font11">courier; </span>
   <span class="font11">curve </span>
   <span class="font11">detected </span>
   <span class="font11">diagnosing </span>
   <span class="font11">em; </span>
   <span class="font11">epidemiological </span>
   <span class="font11">excellent </span>
   <span class="font11">false-positive </span>
   <span class="font11">healthy </span>
   <span class="font11">high </span>
   <span class="font11">highly </span>
   <span class="font11">mainly </span>
   <span class="font11">method </span>
   <span class="font11">methods </span>
   <span class="font11">negative </span>
   <span class="font11">obtained </span>
   <span class="font11">pt;} </span>
   <span class="font11">ranged </span>
   <span class="font11">research </span>
   <span class="font11">reverse </span>
   <span class="font11">samples </span>
   <span class="font11">shown </span>
   <span class="font11">standard </span>
   <span class="font11">study </span>
   <span class="font11">substantial </span>
  </p>
 </body>
</html>
